REDMOND, Wash. , May 17, 2023 /PRNewswire/ -- Cadence Neuroscience announced today that it has secured $26 million in Series B financing. The round was led by Angelini Lumira Biosciences Fund (co-managed by Lumira Ventures and Angelini ...
First human subjects have been treated with ImmunoBrain Checkpoint's novel anti-PD-L1 antibody, IBC-Ab002, in the Phase 1b IBC-01-01 clinical trial NEW YORK , May 17, 2023 /PRNewswire/ -- ImmunoBrain Checkpoint Inc. (IBC), a ...
HANGZHOU, China , May 16, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that the Phase II clinical trial of LNK01001 in the ...
SUZHOU, China , May 11, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the Phase ...
SEATTLE , May 3, 2023 /PRNewswire/ -- Sound Pharmaceuticals is pleased to announce that it has completed enrollment in its first Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory, for the treatment of Meniere's Disease ...
Study commences following green light from the U.S. FDA for Investigational New Drug Application HONG KONG , GERMANTOWN, Md. and SUZHOU, China , April 12, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" , Stock Code: ...
SHANGHAI , April 10, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that it has ...
NEWARK, Del. and NANJING , China , April 4, 2023 /PRNewswire/ -- Biosion USA , Inc. (Biosion), a global clinical-stage R&D biotechnology company, today announced that it has successfully opened an IND following review by the U.S. ...
HANGZHOU, China , April 4, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has recently completed phase I trials in healthy ...
VO659 is the only clinical-stage candidate targeting the CAG repeat expansion that causes these diseases VO659 was designed to preferentially reduce mutant HTT and spare wild-type HTT Phase 1/2a basket trial design and preclinical VO659 ...
Bharat Biotech, in collaboration with Biofabri, a Spanish biopharmaceutical firm, is conducting trials for the first live attenuated vaccine MTBVAC ( ) derived from a human strain of Mycobacterium tuberculosis. These trials aim to assess the safety and ...
A multisite clinical trial offers promising outcomes for patients with metastatic and recurrent uterine cancer, also known as endometrial cancer. Presented at the annual meeting of the Society of Gynecologic Oncologists, the study compiled data from ...
Researchers at the University of Oxford in the UK have initiated the first human clinical trial to evaluate ChAdOx1 NipahB vaccine designed to safeguard individuals against the deadly Nipah virus . ( ) ChAdOx1 NipahB Vaccine Trial with 51 Participants to Combat Nipah Virus Threat Fifty-one people aged 18 to 55 will participate in the ...
The stromal processing peptidase (SPP), a chloroplast plant enzyme, reduces the clumping of proteins that cause the pathogenic alterations in models of Huntingtons disease in human cells and the nematode Caenorhabditis elegans ( ). ...
A group of US researchers, who first conducted an ‘ artificial womb ’ experiment in lamb, are now seeking Food and Drug Administration (FDA) approval for its tests on humans ( ). This could potentially reduce deaths and disability for babies ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers